StemCyte International, Ltd. (TPEX:4178)
Taiwan · Delayed Price · Currency is TWD 28.00
+0.05 (0.18%)
At close: Feb 11, 2026
StemCyte International Market Cap
StemCyte International has a market cap or net worth of 5.38 billion as of February 13, 2026. Its market cap has decreased by -20.27% in one year.
Market Cap
5.38B
Enterprise Value
3.54B
Revenue
385.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.00
Market Cap Chart
Since December 5, 2024, StemCyte International's market cap has decreased from 8.06B to 5.38B, a decrease of -33.21%. That is a compound annual growth rate of -28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 5.38B | -9.53% |
| Dec 31, 2025 | 5.95B | -26.17% |
| Dec 31, 2024 | 8.06B | - |
| Dec 5, 2024 | 8.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kuang Hong Arts Management Incorporation | 5.49B |
| Jarllytec Co. | 5.49B |
| Grand Fortune Securities Co.,Ltd | 5.47B |
| Progate Group | 5.40B |
| Pharmosa Biopharm | 5.40B |
| S-Tech | 5.38B |
| Locus Cell | 5.38B |
| Chialin Precision Industrial | 5.36B |